Author： Edwards Natalie C.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.23, Iss.3, 2005-01, pp. : 299-314
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Long-acting risperidone cost saving in schizophrenia
Inpharma, Vol. 1, Iss. 1517, 2005-01 ,pp. :
Access to resources
Recommend
Long-acting risperidone cost saving in schizophrenia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 492, 2005-01 ,pp. :
Long-acting risperidone adds value in schizophrenia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 443, 2003-01 ,pp. :
Long-Acting Risperidone: A Review of Its Use in Schizophrenia
By Tracy Swainston Harrison Goa K.L.
CNS Drugs, Vol. 18, Iss. 2, 2004-01 ,pp. :